14.8 C
Athens
Friday, November 8, 2024

Haopeng Yang, PhD

Home » Haopeng Yang, PhD Researcher Spotlight: Haopeng Yang, PhD UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER Super-enhancers are regions of the genome responsible for regulating expression of an unusually high number of genes. For his Lymphoma Research Foundation-funded project, Dr. Yang is characterizing the activity of superenhancers in different subtypes of diffuse large B-cell lymphoma (DLBCL),...

Min Xia, PhD

Home » Min Xia, PhD Researcher Spotlight: Min Xia, PhD WEILL CORNELL MEDICINE Among the different subtypes of diffuse large B-cell lymphoma (DLBCL), ABC-DLBCL represents one of the most aggressive forms with low response rates to standard chemotherapeutic approaches. Improved treatment approaches in this space are urgently needed, and an improved understanding of ABC-DLBCL biology may help...

Danielle Wallace, MD

Home » Danielle Wallace, MD Researcher Spotlight: Danielle Wallace, MD UNIVERSITY OF ROCHESTER Mindy Camp Fedida Memorial Scholar Older patients with diffuse large B-cell lymphoma (DLBCL) are often treated with lower doses of chemotherapy, which may contribute to an incomplete cure of the disease. Residual tumor cells in the body release pieces of DNA into the blood and...

Christina Poh, MD

Home » Christina Poh, MD Researcher Spotlight: Christina Poh, MD UNIVERSITY OF WASHINGTON/FRED HUTCHINSON CANCER CENTER Stephanie A. Gregory, MD Distinguished Scholar Survival outcomes with peripheral T-cell lymphoma (PTCL) are poor, with many patients relapsing after their first line of treatment and only about 1 in 5 patients surviving for at least 5 years after diagnosis. To help...

Adam DuVall, MD

Home » Adam DuVall, MD Researcher Spotlight: Adam DuVall, MD UNIVERSITY OF CHICAGO Chike Springer Foundation Scholar Adolescents and young adults with cancers such as lymphoma have unique emotional and psychosocial needs as a result of their disease and treatment. While survival outcomes rates are high, these burdens can lead to long-term, negative consequences and high rates of...

Moah Soan, DVM, PhD

Home » Moah Soan, DVM, PhD Researcher Spotlight: Moah Soan, DVM, PhD ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Jaime Peykoff Follicular Lymphoma Fellow Breakthrough therapies such as chimeric antigen receptor (CAR) T-cell therapies and bispecific antibodies have transformed the care of patients with follicular lymphoma (FL) such that many patients now experience deep and meaningful remissions. A...

Time Management Tips

Weather

Athens
few clouds
14.8 ° C
15.6 °
13.6 °
64 %
5.1kmh
20 %
Fri
18 °
Sat
18 °
Sun
17 °
Mon
16 °
Tue
16 °

Must Read